01Clinician-led medical device development and ODM execution—from unmet clinical needs and product concepts to prototypes and Design for Manufacturing (DFM).

ContactIntegrated MedTech Development & Commercialization Platform
NKH connects clinical insights, AI and field data, product development, regulatory strategy, intellectual property, strategic funding, manufacturing management and commercialization to build and grow clinician-driven MedTech ventures into scalable companies.
One connected ecosystem
With Seoul National University Hospital (SNUH) as a strategic partner, NKH brings together clinical expertise, technical development, regulatory, intellectual property and commercialization capabilities through one integrated platform. We reduce early-stage risk, accelerate development and create enduring value for patients, physicians and partners.
Company builder process
NKH takes responsibility for the full commercialization journey—turning physician-generated clinical insights into scalable, market-ready ventures through a sustainable and systematic incubation process.
Identify unmet clinical needs across a broad range of medical specialties and validate them with frontline medical experts.
Translate validated clinical needs into practical product concepts, prototypes and market-ready medical technologies through clinician-led development, engineering, and collaboration with specialized external R&D partners and government-funded research institutes where appropriate.
Advance regulatory approval, quality systems and market-access strategy to establish a clear pathway toward commercialization.
Build and protect the intellectual property foundation of each product through strategic ownership, portfolio management, licensing and monetization.
Combine strategic investment with government grant opportunities, banking and external financing pathways to provide the right capital at the right stage of development.
Manage production partners, quality, procurement and scale-up to establish reliable, commercialization-ready manufacturing pathways.
Build go-to-market strategies through Key Opinion Leader (KOL) engagement, reference hospitals, global partnerships and channel strategy.
Our ecosystem
Each company brings distinct technical, regulatory, intellectual property and commercialization capabilities. NKH connects these capabilities through one integrated platform to accelerate execution and create greater value.
01
Clinician-led medical device development and ODM execution—from unmet clinical needs and product concepts to prototypes and Design for Manufacturing (DFM).

02
Integrated clinical, regulatory, quality and eGMP capabilities that guide medical technologies from validation through commercialization readiness.

03
Well-established go-to-market capabilities, KOL engagement and channel strategy to commercialize medical technologies and serve patients globally.
Ongoing
04
IP strategy, ownership and monetization designed to turn clinical innovation into lasting enterprise value.
OngoingPeople
Clinicians, engineers, regulatory specialists, operators and business builders work as one team—sharing expertise, responsibility and trust throughout every company-building journey.
Clinical, engineering, regulatory and business perspectives working together.
Shared execution across product development, commercialization and company building.
Teams aligned around outcomes, accountability and trust.
A practical, execution-focused culture that moves ideas toward real businesses.
Clinical Insight · Engineering · Regulatory · Strategy · Commercial Execution
Our impact
We combine clinical expertise, operational execution and trusted networks to move ideas from early concepts to products and companies that create meaningful value.
Clinician-founded Companies · Incubated by NKH
A growing portfolio of MedTech companies built through the NKH platform—from early clinical insights and product development to regulatory readiness, commercialization, and independent growth.
Companies currently being developed, scaled, or commercialized through the NKH platform.



1940 nm thulium fiber laser system for precise BPH treatment and urinary stone lithotripsy.

Integrated biosensor platform for rapid multi-parameter health screening and remote monitoring.
Companies that have progressed through the NKH platform and moved into a more independent stage of growth and commercialization.




Disposable flexible endoscopy system
Earlier ventures and projects that represent the evolution of NKH’s clinician-driven company-building experience.

AI-powered urodynamic and surgical laser systems

Ear, nose and throat (ENT) prediction using blood-flow biomarkers
Build what comes next with NKH.
Contact us